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Abstract
Epidermal growth factor (EGF), which promotes epidermal regeneration and wound closure, is important for the pro-
liferation and differentiation of epidermal and epithelial tissues in animals. Exogenous EGF is a promising therapeu-
tic agent for wound healing, but its general use is restricted by the limited availability of this protein. In this work, we
show that the transfection of mouse BALB/MK keratinocytes, which are totally dependent on EGF for growth and mi-
gration, with mature cDNA for human EGF via a retroviral vector abolished the cells requirement for exogenous EGF.
The transformed cells had normal morphology and a growth rate that varied according to the source of the retroviral
vector used. Keratinocyte transfection with EGF cDNA provides a time- and cost-efficient means of culturing
keratinocytes and yields cells that may be useful for skin grafting.
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Introduction
Epidermal growth factor (EGF) was first isolated
from murine salivary glands (Cohen, 1962). The complete
human EGF (hEGF) sequence (1,207 amino acids) includes
an active EGF sequence, eight EGF-like units and a hydro-
phobic sequence at the carboxy terminal end characteristic
of an integral membrane protein. Active, mature EGF con-
tains only 53 amino acids, six of which are cysteines (Car-
penter and Cohen, 1990).
EGF stimulates the proliferation and differentiation
of epidermal and epithelial tissues in animals, and is there-
fore involved in wound closure and epidermal regeneration
(Carpenter and Cohen, 1979; Moulin, 1995; Gibbs et al.,
2000). In addition, cells cultured with medium containing
EGF share many of the features observed during wound re-
generation (Gibbs et al., 2000). EGF is synthesized by sev-
eral cells involved in the regulation of wound healing,
including platelets and activated macrophages. Human
keratinocytes express four members of the EGF family,
namely, TGF-α (transforming growth factor-α), HB-EGF
(heparin-binding EGF), amphiregulin and epiregulin
(Hashimoto, 2000); the expression of EGF itself in kerati-
nocytes has not yet been demonstrated. EGF receptors are
expressed in cells directly involved in wound healing, in-
cluding skin keratinocytes, fibroblasts, vascular endothelial
cells and gastrointestinal epithelial cells (Schultz et al.,
1987, 1991).
Local and systemic applications of a number of
growth factors have been used to treat chronic wounds
(Brown et al., 1986). Although EGF is an important factor
in wound healing, this mediator also has important interac-
tions with other growth factors such as PDGF (platelet-
derived growth factor), IGF (insulin-like growth factor)
and TGF-β (transforming growth factor-β). Additionally,
EGF receptors are important for the autocrine growth of
normal epidermis (Yates et al., 1991). In wounded skin, the
transient but dynamic elevation of EGF receptors during
wound healing contributes to the migratory potential of
keratinocytes (Hudson and McCawley., 1998), thereby en-
hancing re-epithelialization of the wound.
Topically applied growth factors can accelerate heal-
ing by inducing the migration and proliferation of target
cells, and exogenous EGF is a promising therapeutic agent
in this process (Brown et al., 1986; Steed, 1998). Ideally, a
continuous supply of EGF is required for optimal healing
during the early stages of repair, but this is not always feasi-
ble. An attractive alternative to the constant application of
exogenous growth factor is ex vivo gene transfer by retro-
viral vectors that would allow the continuous delivery of
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EGF to the wound. In this approach, a small piece of tissue
isolated from a patient is expanded into a large number of
cells in culture (Green et al., 1979), transfected with retro-
viral vectors and transplanted to the site of the lesion. Using
this approach, several authors have successfully introduced
a number of genes encoding proteins such as human growth
hormone (Morgan et al., 1987), clotting factor IX (Gerrard
et al., 1993) and apolipoprotein E (Fenjves et al., 1994).
The insulin-like growth factor-1 gene (IGF-1), which en-
codes another important non-autocrine growth factor for
keratinocytes, has been successfully transferred to kera-
tinocyes by retroviral vectors; the resulting cells were no
longer dependent on exogenous IGF, but still required
supplementation with exogenous EGF (Eming et al., 1996).
In this report, we describe the successful transduction
with a retroviral vector and expression of mature human
EGF (hEGF) cDNA in mouse BALB/MK keratinocytes
(Weissman and Aaronson, 1983) that are normally totally
dependent on EGF for growth and migration.
Materials and Methods
Retroviral vectors
A vector containing hEGF cDNA was obtained from
the American Tissue Culture Collection (ATCC, catalog
no. 20658). The plasmid was digested with Bam HI to re-
lease a 1.7 kb insert that was subcloned into pBluescript SK
(Stratagene) pretreated with the same enzyme. From this
product, a cassette containing the hEGF sequence with the
signal peptide sequence was isolated with Eco RI and Sal I,
and subcloned into the retroviral vector pLXSN (Miller and
Rosman, 1989) previously digested with the same enzy-
mes. This vector was denominated as LESN.
The method for virus production has been described
in detail elsewhere (Miller et al., 1993). Briefly, the vectors
LESN and LXSN (control) in plasmid form were used to
transfect PE501 ecotropic packaging cells, and the super-
natants were used to infect PA317 amphotropic packaging
cells. After selection with G418, resistant colonies were
isolated and expanded to generate clonal vector-producing
cell lines followed by determination of the viral titer.
DNA sequencing
DNA was sequenced by the dideoxy method (Sanger
et al., 1977) using a T7 Sequenase kit (USB Amersham
Life Science) according to the manufacturers instructions.
Three primers based on the vector pBluescript SK (Stra-
tagene) (Reverse, KS, M13-20) were used for this sequenc-
ing.
Cell culture and virus production
The amphotropic retrovirus-producing cell clone
PA317/LESN was cultured in Dulbeccos modified Eagle
medium (DMEM) with high glucose (4.5 g/mL), supple-
mented with 2 mM glutamine, 200 U of penicillin/mL,
200 mg of streptomycin/mL and 10% fetal bovine serum
(FBS; Gibco) at 37 °C in a humidified atmosphere with 5%
CO2.
The murine keratinocyte cell line, BALB/MK (kindly
provided by Dr. Stuart A. Aaronson), was cultured in Ea-
gles minimum essential medium (EMEM; Biofluids Inc,
Rockvill, MD) with low Ca2+ (0.05 mM) supplemented
with 10% FBS and 5 ng of EGF/mL (Sigma) at 37 °C in a
humidified atmosphere with 5% CO2.
Cell migration assay
BALB/MK cells (5 x 104 per well) were seeded on
24-well plates and PA317/LESN or PA317/LXSN (con-
trol) cells (3.5 x 105 per well) were similarly seeded on
12-well plates. After 24 h, the culture medium was replaced
with fresh medium. The following day, viruses were col-
lected from PA317/LESN or PA317/LXSN cells and cen-
trifuged at 10,000 x g for 1 min in an Eppendorf centrifuge.
In the plate containing BALB/MK cells, a yellow pipet tip
was used to scrape a line through the cell monolayer in each
well and the wells were then washed with PBS (phos-
phate-buffered saline) to remove the detached cells. This
was followed by the addition of 0.5 mL of virus solution
(1 x 105 cfu) containing 8 μg of Polybrene/mL to each well
of BALB/MK cells. Cell migration was observed with an
inverted microscope (Nikon). After 48 h, the cells were
washed with PBS, fixed with methanol:acetone (1:1, v/v)
for 4 min and stained with 0.5% Coomassie brilliant blue G
in 35% ethanol and 10% glacial acetic acid for 2 min. The
cells were then washed with distilled water and photo-
graphed.
Results and Discussion
Vectors and PA317 packaging cell clones
In this work, BALB/MK cells were transfected with
the retroviral vector LESN. Initially, the DNA of a vector
containing hEGF cDNA was sequenced and found to con-
tain a 1.3 kb cassette with sequences for the S. cerevisiae
signal peptide and mature hEGF between Eco RI and Sal I
restriction sites (Figure 1). The amino acid sequence for
hEGF contained three changes in the N-terminus com-
pared to the original sequence reported by Bell et al.
(1986). However, these changes do not affect the proteins
biological activity (ATCC product information), and this
was confirmed by the cell migration assay described be-
low.
In the experiments described here, an expression
cassette containing only the mature hEGF sequence was
used since the entire hEGF cDNA is > 5 kb and such a
large insert tends to decrease the viral titer of packaging
clones. As expected, most of the PA317/LESN clones had
a viral titer > 1 x 105 cfu/mL, particularly clone 9 which
had a titer 10-fold greater than most of the other clones. In
all of the clones shown in Table 1 the LESN vector was in-
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tegrated into the cellular genomic DNA (not shown), as is
characteristic of retroviral vectors (assayed by Southern
blotting).
Effects of EGF on BALB/MK cells modified with
LESN
Initially, we determined effects of exogenous EGF on
the growth of BALB/MK cells by using the cell migration
assay. Since EGF is one of the most important factors for
stimulating cell growth, we examined the ability of a com-
bination of EGF (10 ng/mL) and 10% FBS to promote cell
growth compared to the response triggered by EGF and
FBS separately. The concentration of EGF used was chosen
based on a dose-response curve for this growth factor in
BALB/MK cells in which concentrations > 10 ng/mL did
not significantly increase the cellular response beyond that
seen with 10 ng/mL.
As expected, BALB/MK cells cultured only with
EMEM showed no observable migration (Figure 2A). In
contrast, cells incubated with 10 ng of EGF/mL or 10%
FBS showed intermediate migration when compared to
those incubated with both (Figures 2B-D). The effect of
EGF and FBS on BALB/MK cell growth differed: cells in-
cubated with EGF were more dispersed (indicating moto-
genic activity) whereas those incubated with FBS formed a
dense layer (indicating greater mitogenicity and less moto-
genicity), as previously reported for primary cultures of
keratinocytes (Rheinwald and Green, 1977; Barrandon and
Green, 1987).
Since cellular migration was greater in medium con-
taining FBS and EGF, we used medium containing 10%
FBS to assess the migration of BALB/MK cells modified
with LESN. Of the PA317/LESN clones shown in Table 1,
clones 2, 4 and 6 had more pronounced foci of cell migra-
tion (Figure 3). However, the cellular migration stimulated
by the PA317/LESN clones was not totally independent of
EGF since during the assay exogenous EGF was added to
the medium to facilitate retroviral infection (see Materials
and Methods).
To demonstrate the self-stimulated growth of trans-
formed BALB/MK cells, the cells were selected with G418
and seeded onto new plates in the absence of exogenous
EGF (Figure 4). Cells transformed with clone 6 showed
greater growth than those transformed with viruses from
PA317/LXSN (negative control) or PA317/LESN clone 9
(low cellular migration) (Figure 4). BALB/MK cells trans-
formed with clone 6 reached confluence 6-7 days after
infection, which was similar to the time required for non-
transformed BALB/MK cells to reach confluence in the
presence of exogenous EGF. In contrast, cells infected with
the negative control virus (LXSN) or LESN clone 9 did not
reach confluence even after two weeks in culture; indeed,
most of the cells died before two weeks if EGF was not
added to the culture (not shown).
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Figure 1 - DNA sequence of hEGF subcloned into the retroviral vector.
The open reading frame of hEGF is underlined and the signal peptide is in
italics. Codons that differ from the original hEGF sequence (Bell et al.,
1986) are in bold.
Figure 2 - Effect of EGF and/or FBS on BALB/MK cell migration.
BALB/MK cells were grown as described in Methods. Except for the day
of virus infection, the medium was replaced by new one without EGF and
FBS (A), with 10 ng EGF/mL (B), with 10 ng EGF/mL and 10% FBS (C)
or with 10% FBS (D). After incubation for 48 h, the cells were fixed and
stained with Coomassie blue. Magnification: 100X.
Table 1 - Viral titer of PA317/LESN clones.
PA317/LESN Titer (cfu/mL)
Clone 2 4.0 x 105
Clone 3 1.0 x 105
Clone 4 < 105
Clone 5 < 105
Clone 6 9.0 x 105
Clone 7 3.0 x 105
Clone 9 3.8 x 106
cfu = colony forming units.
For the cell migration assay, BALB/MK cells were
transformed with the same volume of virus from
PA317/LESN clones. Since the viral titer differed among
the clones, the number of infected BALB/MK cells was
also different. Consequently, cells incubated with a higher
viral concentration supposedly had a greater level of EGF
production and greater migration. However, PA317/LESN
clone 9, which had a viral titer > 1 x 106 cfu/mL, grew less
than clone 6, which had a lower titer (Figure 4). The most
likely explanation for this discrepancy is that the viral DNA
incorporated into the cells suffered mutations or rearrange-
ments that resulted in a low level of EGF gene expression.
This hypothesis was supported by the finding that the viral
genome in PA317/LESN clone 9 was smaller than that of
the other clones, as shown by Southern blotting after diges-
tion with Sal I, which cleaves in both LTR regions (not
shown). In addition, northern blotting revealed a strong
band of EGF RNA only in clone 6 (not shown). The latter
finding supports the idea that a rearrangement of DNA in
clone 9 resulted in low expression of EGF. Clone 4 of
PA317/LESN had a viral titer < 1 x 105 cfu/mL but caused
greater migration than clones 3 and 9, both of which had
higher titers (Table 1 and Figure 3), probably also because
of rearrangements in its genomic DNA (not shown). To-
gether, these results indicate the need to carefully analyze
genetically modified cells in order to identify the DNA re-
arrangement involved.
In conclusion, keratinocytes transformed by intro-
ducing the hEGF gene can be cultured without exogenous
EGF. These modified cells should be useful for short-term
skin grafting because they do not require a continuous sup-
ply of exogenous EGF. Since most keratinocytes have a
limited life span, EGF production in vivo will cease when
the transformed cells die, thereby minimizing the danger of
keratinocytes permanently expressing this growth factor.
Nevertheless, since keratinocytes that have been geneti-
cally modified by retroviral vectors are subject to inser-
tional mutagenesis that can activate oncogenes, these
modified cells require rigorous genetic analysis before their
long-term use in vivo is approved.
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